Who
In numbers
- Trades disclosed
- 57
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $287K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 Aug 2018
- Last trade
- 25 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Sep 2026filed 29 Sep 2026 | IGC IGC PharmaBiotechnology | SEC FORM 4 Code G | —150,000 at $0.00 | filing |
| 25 Sep 2026filed 29 Sep 2026 | IGC IGC PharmaBiotechnology | SEC FORM 4 Code G | —150,000 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | IGC IGC PharmaBiotechnology | SEC FORM 4 Code A | $553K2,048,378 at $0.27 | filing |
| 30 Jun 2026filed 1 Jul 2026 | IGC IGC PharmaBiotechnology | SEC FORM 4 Code A | $553K2,048,378 at $0.27 | filing |
| 1 Apr 2026filed 6 Apr 2026 | IGC IGC PharmaBiotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 1 Apr 2026filed 6 Apr 2026 | IGC IGC PharmaBiotechnology | SEC FORM 4 Code M | $36K138,462 at $0.26 | filing |
| 1 Apr 2026filed 6 Apr 2026 | IGC IGC Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 1 Apr 2026filed 6 Apr 2026 | IGC IGC Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 1 Apr 2026filed 6 Apr 2026 | IGC IGC Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —138,462 at $0.00 | filing |
| 1 Apr 2026filed 6 Apr 2026 | IGC IGC Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —138,462 at $0.00 | filing |
| 1 Apr 2026filed 6 Apr 2026 | IGC IGC PharmaBiotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 1 Apr 2026filed 6 Apr 2026 | IGC IGC PharmaBiotechnology | SEC FORM 4 Code M | $36K138,462 at $0.26 | filing |
| 17 Oct 2025filed 21 Oct 2025 | IGC IGC Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 17 Oct 2025filed 21 Oct 2025 | IGC IGC Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 17 Oct 2025filed 21 Oct 2025 | IGC IGC PharmaBiotechnology | SEC FORM 4 Code G | —50,000 at $0.00 | filing |
| 31 Mar 2025filed 15 May 2025 | IGC IGC Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —58,333 at $0.00 | filing |
| 31 Mar 2025filed 15 May 2025 | IGC IGC Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 31 Mar 2025filed 15 May 2025 | IGC IGC PharmaBiotechnology | SEC FORM 4 Code M | —58,333 at $0.00 | filing |
| 31 Mar 2025filed 15 May 2025 | IGC IGC PharmaBiotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 13 Mar 2024filed 15 Mar 2024 | IGC IGC Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —83,333 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.